FORT WORTH (WBAP/KLIF)- Ventavia Research Group, LLC is conducting Covid-19 Vaccine Trials for expecting mothers.
The study calls for 4,000 healthy pregnant women in their late second or early third trimester who haven’t previously had Covid-19
The research group said it will help determine how the mother will begin to build antibodies and how it will transfer to the baby through the umbilical cord.
Pregnant women are already a part of phase 1B to get the vaccine, the group hopes this study will help them make an informed choice in the future when it comes to getting the vaccine.
Ventavia Research Group has done other Covid-19 clinical trials before, but not specifically for pregnant women and plans to start trials for pediatric patients in the next couple of months.
Click here for more information.
